Crosslink Therapeutics
Boston, US · Founded 2021 · Delaware corporation · 1 known investors
Find your way into Crosslink Therapeutics
Sign up to see every warm intro you have to Crosslink Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Crosslink Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
RD
Ronald D. Seidel, IIINamed on SEC filing
Board
CG
Cameron GallagherBoard director
LT

RC
Rodolfo ChaparroBoard director
AK

Investors · 1
Cure Ventureslisted by Cure VenturesBostonvia Lou Tartaglia · board
How we know: board seat on SEC Form D · funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$4.3M disclosed across 1 round · 2025
▶$4.3MraisedMay 2025 · 6 investors · PharmaceuticalsRule 506(b)
▶$4.3MraisedMay 2025 · 6 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Ronald D. Seidel, IIIExecutive Officer, Director
- Cameron GallagherDirector
- Lou TartagliaDirector
- Rodolfo ChaparroDirector
- Andrew KingExecutive Officer
- Offering amount
- $8M
- Amount sold
- $4.3M
- First sale
- Apr 2025
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Crosslink Therapeutics went on to found or lead other companies.
Frequently asked questions
- Who are Crosslink Therapeutics's investors?
- Crosslink Therapeutics's investors include Cure Ventures.
- How much funding has Crosslink Therapeutics raised?
- Crosslink Therapeutics has disclosed $4.3M raised across 1 round.
- Where is Crosslink Therapeutics headquartered?
- Crosslink Therapeutics is headquartered in Boston, US.
